NCT06759259Completed
Mannitol Administration for Delerium Prevention
Mannitol Adjuvant Administration for Delerium Prevention
Source: ClinicalTrials.gov · Last updated 24 Jun 2026
Brief summary (registry, in English)
The aim of the study is to evaluate the efficacy of adjuvant administration of mannitol for the prevention of delirium in patients with myocardial infarction.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 50 (actual)
- First submitted
- 28 Dec 2024
- Start date
- 29 Dec 2024
- Primary completion date
- 1 Feb 2025
- Lead sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Diseases
- Coronary artery disease
- NCT number
- NCT06759259
What you commit to
- Study type: Observational
- Participants enrolled: 50
- From 29 Dec 2024 to the primary completion date, 1 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- A known pathological process in the brain, psychiatric disorders
Other
- Impossibility of conducting an assessment CAM-ICU
Who the study is looking for
- Age 65 and over
- Myocardial infarction in the first day of illness ("pain to door" time \< 254 hours)
- Serum CRP \> 25 mg/L
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cardiology Reserch Institute Tomsk National Research Centre Coordinator of this site? Confirm its status | Tomsk | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.